Malin Corporation | MLC - Market Capitalization


Malin Corporation reported EUR144.8M in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 427M 297M Dec/2025
Alaunos Therapeutics USD 5M 5M Sep/2025
ALKERMES USD 4.62B 333M Dec/2025
Avita Medical AUD 105.47M 35.32M Dec/2025
Dianthus Therapeutics USD 1.78B 215M Dec/2025
Eurofins Scientific SE EUR 11.37B 357.04M Dec/2025
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
IQVIA Holdings USD 38.39B 6.1B Dec/2025
Lonza CHF 39.68B 980.61M Jun/2025
Malin Corporation EUR 142.92M 19.65M Feb/2026
Organon & Co USD 1.86B 916.43M Dec/2025
Ovoca Bio EUR 6.12M 4.93M Apr/2026
Revvity USD 10.97B 1.21B Dec/2025
Tectonic Therapeutic USD 390M 96M Dec/2025
Viatris USD 14.34B 2.8B Dec/2025
Xeris Pharmaceuticals USD 1.3B 12M Dec/2025